+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Sienna Biopharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Press Release Sienna Biopharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results | RobinsPost News & Noticias

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update


Positive Business Momentum and Sales Pipeline Growth Following FDA 510(k) Clearance of Vivos’ Proprietary Oral Medical Devices to Treat Severe ... Read More

Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results


Total consolidated revenue for 2023 was $27.5 million, up slightly from $27.4 million achieved in 2022. Total revenue, excluding BioXp instrument sales and discontinued BioFoundry Services operations, ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus